课题基金 / 基金详情

Granulocytic Ehrlichiosis: Cell-Pathogen Interactions

Granulocytic Ehrlichiosis: Cell-Pathogen Interactions
粒细胞埃利希体病:细胞-病原体相互作用
批准号:
6869625
负责人:
DORI L. BORJESSON
金额:
$12.81万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-04-01 至 2006-03-31

项目摘要

项目成果

DORI L. BORJESSON的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Human granulocytic ehrlichiosis (HGE) is an emerging, potentially fatal, tick-borne zoonotic disease caused by an obligate intracellular bacterium. Although Anaplasma phagocytophila, formerly the HGE agent, lives and replicates primarily within granulocytes, multiple cytopenias, especially thrombocytopenia, are a consistent hallmark of infection. The interaction of A. phagocytophila with neutrophils and platelets in vivo and the manner in which these interactions contribute to infection efficiency, cytopenias, pathogen distribution and transmission are still unclear. The goal of this project is to understand pathogen interaction with host cells in light of hematologic abnormalities and in vivo infection kinetics utilizing a murine model of HGE and in vitro cell techniques. Study objectives are first, to determine leukocyte and platelet interaction with, and response to, A. phagocytophila and, second, to determine the role, if any, these interactions play in determining pathogen distribution and transmission. The central hypothesis for the proposed research, based on preliminary data, is that during early infection, A. phagocytophila adheres to and activates both granulocytes and platelets resulting in alterations in cell adhesion and distribution that directly affect cell-pathogen trafficking and facilitate pathogen replication and transmission. The proposed work is focused on an emerging, zoonotic disease with potentially serious hematologic alterations. Significant positive impacts of this work will include enhanced understanding of in vivo bacterial pathogenesis as well as elucidation of possible targets for interruption of the transmission cycle from animal host to tick vector. The purpose of the proposed Mentored Clinical Scientist Development (KO8) award is to provide the candidate with the mentoring and resources needed for transition into the position of an independent academic clinician-scientist. The award is ideally suited to this candidate who has completed her professional veterinary degree, clinical pathology training and PhD in Comparative Pathology but has not completed postdoctoral research training. Currently, the candidate is a junior faculty member at a strong research institution with a clear mandate and desire to pursue an independent research program.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
Culture, isolation, and labeling of Anaplasma phagocytophilum for subsequent infection of human neutrophils.
培养、分离和标记嗜吞噬细胞无形体,用于随后感染人中性粒细胞。
DOI: 10.1007/978-1-60327-032-8_13
发表时间: 2008
期刊: Methods in molecular biology (Clifton, N.J.)
影响因子: --
作者: [Borjesson,DoriL]
通讯作者: Borjesson,DoriL
Anaplasma phagocytophilum infects cells of the megakaryocytic lineage through sialylated ligands but fails to alter platelet production.
嗜吞噬细胞无形体通过唾液酸化配体感染巨核细胞谱系的细胞,但不能改变血小板的产生。
DOI: 10.1099/jmm.0.47551-0
发表时间: 2008
期刊: Journal of medical microbiology
影响因子: 3
作者: [Granick,JenniferL, Reneer,DexterV, Carlyon,JasonA, Borjesson,DoriL]
通讯作者: Borjesson,DoriL
Mesenchymal Stem Cell Therapy for Gut Mucosal Recovery in the SIV Model of AIDS
  • 批准号:
    8847248
  • 项目类别:
  • 资助金额:
    $23.45万
  • 财政年份:
    2015
  • 负责人:
    DORI L. BORJESSON
  • 依托单位:
An Animal Model of Chronic Oral Inflammation for Stem Cell-Based Therapy
  • 批准号:
    8747852
  • 项目类别:
  • 资助金额:
    $15.56万
  • 财政年份:
    2014
  • 负责人:
    DORI L. BORJESSON
  • 依托单位:
An Animal Model of Chronic Oral Inflammation for Stem Cell-Based Therapy
  • 批准号:
    8889665
  • 项目类别:
  • 资助金额:
    $15.65万
  • 财政年份:
    2014
  • 负责人:
    DORI L. BORJESSON
  • 依托单位:
Granulocytic Ehrlichiosis: Cell-Pathogen Interactions
  • 批准号:
    6611628
  • 项目类别:
  • 资助金额:
    $11.02万
  • 财政年份:
    2003
  • 负责人:
    DORI L. BORJESSON
  • 依托单位: